null

SMILES: Cc1cc(Nc2cc3nc(CN4CCOCC4)ccc3c(N[C@@H]3C[C@@H]4CCC[C@H](C3)N4CC(F)(F)F)n2)n[nH]1

InChI Key: InChIKey=UNTPIVQPYGUHPI-WKCHPHFGSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 487307   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM487307 (US10947254, Example 5-29) Show SMILES Cc1cc(Nc2cc3nc(CN4CCOCC4)ccc3c(N[C@@H]3C[C@@H]4CCC[C@H](C3)N4CC(F)(F)F)n2)n[nH]1 |THB:31:30:27.26.25:22.29.23| Show InChI InChI=1S/C27H35F3N8O/c1-17-11-25(36-35-17)33-24-14-23-22(6-5-18(31-23)15-37-7-9-39-10-8-37)26(34-24)32-19-12-20-3-2-4-21(13-19)38(20)16-27(28,29)30/h5-6,11,14,19-21H,2-4,7-10,12-13,15-16H2,1H3,(H3,32,33,34,35,36)/t19-,20+,21-	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Biopharma R&D IP, LLC US Patent					Assay Description A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...				US Patent US10947254 (2021)
					More data for this Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM487307 (US10947254, Example 5-29) Show SMILES Cc1cc(Nc2cc3nc(CN4CCOCC4)ccc3c(N[C@@H]3C[C@@H]4CCC[C@H](C3)N4CC(F)(F)F)n2)n[nH]1 |THB:31:30:27.26.25:22.29.23| Show InChI InChI=1S/C27H35F3N8O/c1-17-11-25(36-35-17)33-24-14-23-22(6-5-18(31-23)15-37-7-9-39-10-8-37)26(34-24)32-19-12-20-3-2-4-21(13-19)38(20)16-27(28,29)30/h5-6,11,14,19-21H,2-4,7-10,12-13,15-16H2,1H3,(H3,32,33,34,35,36)/t19-,20+,21-	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.550	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Biopharma R&D IP, LLC US Patent					Assay Description A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...				US Patent US10947254 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM487307 (US10947254, Example 5-29) Show SMILES Cc1cc(Nc2cc3nc(CN4CCOCC4)ccc3c(N[C@@H]3C[C@@H]4CCC[C@H](C3)N4CC(F)(F)F)n2)n[nH]1 |THB:31:30:27.26.25:22.29.23| Show InChI InChI=1S/C27H35F3N8O/c1-17-11-25(36-35-17)33-24-14-23-22(6-5-18(31-23)15-37-7-9-39-10-8-37)26(34-24)32-19-12-20-3-2-4-21(13-19)38(20)16-27(28,29)30/h5-6,11,14,19-21H,2-4,7-10,12-13,15-16H2,1H3,(H3,32,33,34,35,36)/t19-,20+,21-	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.550	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Biopharma R&D IP, LLC US Patent					Assay Description A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...				US Patent US10947254 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM487307 (US10947254, Example 5-29) Show SMILES Cc1cc(Nc2cc3nc(CN4CCOCC4)ccc3c(N[C@@H]3C[C@@H]4CCC[C@H](C3)N4CC(F)(F)F)n2)n[nH]1 |THB:31:30:27.26.25:22.29.23| Show InChI InChI=1S/C27H35F3N8O/c1-17-11-25(36-35-17)33-24-14-23-22(6-5-18(31-23)15-37-7-9-39-10-8-37)26(34-24)32-19-12-20-3-2-4-21(13-19)38(20)16-27(28,29)30/h5-6,11,14,19-21H,2-4,7-10,12-13,15-16H2,1H3,(H3,32,33,34,35,36)/t19-,20+,21-	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.550	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Theravance Biopharma R&D IP, LLC US Patent					Assay Description A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...				US Patent US10947254 (2021)
					More data for this Ligand-Target Pair